NEW AWARD: TARGETING THE DRIVERS OF ANDROGEN RECEPTOR PATHWAY-INDEPENDENT PROSTATE CANCER...EFFECTIVE 7/1/2020 SIGNED 1/17/2020, DISTRIBUTED 1/22/2020, FAADC 1/22/2020
$350,781FY2020Defense Health AgencyDOD
Fred Hutchinson Cancer Research Center, Seattle WA